ZINZINO AB (PUBL.): ZINZINO ACQUIRES 49% OF CYPRIOT OLIVE OIL PRODUCER CLEANTHI ALPHA-OLENIC LTD
GOTHENBURG, Sweden, June 27, 2024 /PRNewswire/ — Zinzino has today acquired 49% of the shares and votes in the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD (“Cleanthi or the Company”). The acquisition is another strategically important step in Zinzino’s growth plans f
China to permit visa-free entry for Australia and New Zealand
BEIJING, June 27, 2024 /PRNewswire/ — News reported by China Matters. China has announced to implement unilateral visa-free policy to Australia, allowing Australian passport holders to enter the country for business, tourism, and transit without a visa for up to 15 days. The two countries also
Pistola emerges as a victorious craft Agave spirit with 32+ Global and Indian Accolades
The brand’s recent laurels include a Double Gold at SIP Awards, two Gold medals at Asian Spirits Masters 2024, and four Silver medals at the International Wine and Spirits Competition 2024 NEW DELHI, June 27, 2024 /PRNewswire/ — Maya Pistola Agavepura (Pistola), Asia’s premium age
Reliance Retail Presents The Wedding Collective: A One-Stop Destination for the Dream Wedding
~Featuring the country’s leading couturiers, trousseau designers, gourmet artisans, beauty experts, jewellers, accessory specialists and bespoke gifting services, this landmark event promises to showcase extraordinary creations~ MUMBAI, India, June 27, 2024 /PRNewswire/ — Reliance Retail
Accor, Paris 2024 Premium Partner, unveils its press kit
A month to go before the start of Paris 2024 Olympics and Paralympics Games and Accor unveils its press kit regarding its partnership. PARIS, June 27, 2024 /PRNewswire/ — As a Premium Partner of Paris 2024, Accor will roll out its complete vision of hospitality throughout the Athletes and Med
Fostrox + Lenvima® holds promise of greatly improved outcomes for advanced liver cancer patients, reveals new data from Medivir at ESMO GI
New results from Medivir’s Phase 1b / 2a open label trial of fostrox + Lenvima® show great promise treating second-line hepatocellular carcinoma (HCC) patients, an extremely hard to treat population Fostrox + Lenvima® achieved a 24% overall response rate (ORR) and estimated median time to pr
Soft2Bet launches the “Soft2Bet Invest” iGaming Innovation Fund
SLIEMA, Malta, June 27, 2024 /PRNewswire/ — Soft2Bet is delighted to announce the launch of ‘Soft2Bet Invest’, its iGaming Innovation Fund that will provide financial and business support to iGaming and casual gaming entrepreneurs who have the same drive for innovation and growth a
Resolution Therapeutics Receives MHRA Approval to Commence Phase I/II EMERALD Study for Lead Candidate RTX001
EMERALD Study will investigate safety and efficacy of engineered macrophage cell therapy in patients with decompensated liver cirrhosis LONDON and EDINBURGH, Scotland, June 27, 2024 /PRNewswire/ — Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical co
Tom Tacon appointed Business Unit Director of Bionical Virtual Engagement
WILLINGTON, England, June 27, 2024 /PRNewswire/ — Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare companies and the NHS, today announced the appointment of Tom Tacon as Business Unit Director of Bion
World Travel Holdings Ranked In Top 20 Of Travel Weekly’s 2024 Travel Agency Power List
Annual survey includes the largest, most successful retailers in the industry WAKEFIELD, Mass. , June 27, 2024 /PRNewswire/ — Industry powerhouse World Travel Holdings announces it ranked #16 in Travel Weekly’s 2024 Power List of the industry’s top retail travel agencies. The Powe
